What caused the pre-market drop in NANO.PA stock today?

The pre-market fall of **11.72%** to **€29.00** was driven by profit-taking after a big rally, heavy relative volume (**2.58x**) and traders reacting to recent trial updates and corporate filings.

How does Meyka AI rate NANO.PA stock and what does it mean?

Meyka AI rates NANO.PA with a score out of 100: **73.83** (Grade **B+**, Suggestion: **BUY**). The grade combines benchmark, sector, growth, metrics and forecasts. It is informational and not financial advice.

What are realistic near-term price targets for NANO.PA stock?

Near-term technical levels: support **€28.00**, resistance **€34.10**. Conservative targets: **€25.00** (bear), **€30.00** (base). Meyka 3-year model projects **€43.66**, reflecting long-term upside potential.

When is the next key event for Nanobiotix that could move the stock?

Earnings are scheduled for **2026-03-31**, and ongoing trial readouts with Janssen remain primary catalysts. These events can create significant price moves in this biotech stock.

EU Stocks

Pre-market: NANO.PA Nanobiotix S.A. down 11.72% on 12 Mar 2026: watch catalysts

ByHuzaifa Zahoor March 12, 2026March 12, 2026

NANO.PA stock opened the pre-market session sharply lower after profit-taking and block trades pushed the price to €29.00, down 11.72% from the previous close. The fall follows a recent strong run for Nanobiotix S.A. (NANO.PA) on EURONEXT and higher-than-average volume of 465,299 shares. Traders should note the stock opened at €34.10 and the day low touched €28.90, highlighting intraday volatility in this biotechnology name in Europe.